lobbying_activities: 600968

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
600968	4b9193e8-486f-4614-85ee-0559c7a33f33	Q1	GENENTECH, INC	15920	GENENTECH INC	2008	first_quarter	PHA	H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price competition and Innovation Act of 207, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.r. 4911, Human Growth Hormone Restriction Act of 2007	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE		591000	0	0	2008-04-18T15:27:48-04:00